A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

December 30, 2014

Primary Completion Date

September 25, 2017

Study Completion Date

July 17, 2020

Conditions
Behçet's Syndrome
Interventions
DRUG

Apremilast

Tablets for oral administration

DRUG

Placebo

Tablets for oral administration

Trial Locations (63)

10016

NYU Langone Medical Center, New York

10107

Charite Universitaetsmedizin Berlin, Berlin

11215

New York Methodist Hospital, Brooklyn

11527

Laiko General Hospital of Athens, Athens

13385

Hopital de La Conception, Marseille

16499

Ajou University Hospital, Suwon

19104

University of Pennsylvania Health Systems, Philadelphia

22763

Asklepios Rheumazentrum Hamburg, Hamburg

26480

Eskisehir Osmangazi University, Eskişehir

30342

Arthritis and Rheumatology of Georgia, Atlanta

31048

Bnai Zion Medical Center, Haifa

31096

Rambam Health Care Campus, Haifa

32174

Millennium Research, Ormond Beach

34098

Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul

34899

Marmara University Hospital, Istanbul

42080

Selcuk University Medical Faculty, Konya

42100

Arcispedale Santa Maria Nuova, Reggio Emilia

48081

Shores Rheumatology, Saint Clair Shores

48910

Advanced Rheumatology, Lansing

49100

Rabin Medical Center, Petah Tikva

50134

Azienda Ospedaliero Universitaria Careggi, Florence

52621

Chaim Sheba Medical Center, Ramat Gan

54642

Ippokratio General Hospital of Thessaloniki, Thessaloniki

60611

Northwestern University Feinberg School of Medicine, Chicago

75013

Pitié-Salpêtriere Hospital Paris, Paris

75014

Hopital Cochin, Paris

75475

Hospital Saint Louis, Paris

85032

Arizona Arthritis and Rheumatology Research, PLLC, Phoenix

85100

Azienda Ospedaliera Regionale San Carlo, Potenza/Matera

87131

University of New Mexico, Albuquerque

91120

Hadassah Medical Organization, Jerusalem

95816

University of California Davis Medical Center, Sacramento

302799

Chungnam National University Hospital, Daejeon

06847

Stadtisches Klinikum Dessau, Dessau

115 21

Navy Hospital of Athens, Athens

115 27

Athens General Hospital 'G Gennimatas', Athens

113-8519

Medical Hospital of Tokyo Medical and Dental University, Bunkyo-ku, Tokyo

113-8602

Nippon Medical School Hospital, Bunkyō City

104-8560

St. Luke's International Hospital, Chūōku

183-8524

Tokyo Metropolitan Tama Medical Center, Fuchu-shi

670-8540

Japanese Red Cross Society Himeji Hospital, Himeji-shi

350-0495

Saitama Medical University Hospital, Iruma-gun, Saitama

173-8606

Teikyo University Hospital, Itabashi-ku

173-8610

Nihon University Itabashi Hospital, Itabashi-ku

216-8511

St Marianna University School of Medicine Hospital, Kawasaki, Kanagawa

807-8556

University of Occupational and Environmentall Health, Kitakyushu

761-0793

Kagawa University Hospital, Miki-cho

849-8501

Saga Medical School Hospital, Saga

228-8555

Kitasato University Hospital, Sagamihara

060-8543

Sapporo Medical University Hospital, Sapporo, Hokkaidô

060-8648

Hokkaido University Hospital, Sapporo, Hokkaidô

750-8520

Shimonoseki City Hospital, Shimonoseki

160-0023

Tokyo Medical University Hospital, Shinjyuku-ku

901-0243

Tomishiro Central Hospital, Tomigusuku-shi

791-0295

Ehime University Hospital, Tōon

213-8507

Yokohama City University Hospital, Yokohama, Kanagawa

Unknown

Hotel Dieu de France, Beirut

Ain Wazein Hospital, El Chouf

American University of Beirut Medical Center, El Chouf

03080

Seoul National University Hospital, Seoul

120-752

Severance Hospital, Yonsei University Health System, Seoul

143-729

Konkuk University Hospital, Seoul

01330

Cukurova University Medical Faculty Balcali Hospital, Adana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT02307513 - A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease | Biotech Hunter | Biotech Hunter